G1 Therapeutics.

PositionRESEARCH TRIANGLE PARK

G1 Therapeutics filed for an initial public offering that could raise as much as $115 million, The company develops cancer drugs. Largest shareholders include Durham-based Hatteras Venture Partners and Wilmington-based...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT